{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000048","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.878977+00:00","generated_at":"2026-05-24T12:59:00.835559+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NeoGenomics promotes Warren Stone to President & COO; COO Melody Harris to depart in May","bullets":["Warren Stone promoted from CCO to President & COO effective April 1, 2025; retains commercial duties and adds lab operations, data solutions, enterprise operations.","Melody Harris, current COO, will depart at end of May 2025; the COO position is eliminated.","Stone's base salary raised to $650,000, target bonus 70% of salary, annual equity target $3M; receives incremental $1M equity grant on April 1.","Incoming CEO Tony Zook says alignment of commercial and operations teams increases agility and supports growth strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000048","json":"https://secwatch.observer/filing/0001077183-25-000048.json","markdown":"https://secwatch.observer/filing/0001077183-25-000048.md","text":"https://secwatch.observer/filing/0001077183-25-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000048/0001077183-25-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000048/neo-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T12:59:00.835559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d6d0c72ab","claim":"Melody Harris departed as Chief Operations Officer at NEOGENOMICS INC.","evidence_excerpt":"Additionally, on March 18, 2024, the Company announced that the Chief Operations Officer position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer, will no longer hold such role and will no longer be a named executive officer effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000048/0001077183-25-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departing"},{"label":"Role","value":"Chief Operations Officer"}],"fact_type":"executive_change"},{"claim_id":"f13d5c070f","claim":"Warren Stone changed role as President & Chief Operating Officer at NEOGENOMICS INC.","evidence_excerpt":"On March 18, 2025, NeoGenomics, Inc. (the \"Company\") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000048/0001077183-25-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"President & Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}